Immunomodulatory aspects in the progression and treatment of oral malignancy

• Prif Awduron: Nobuo Kondoh (Awdur), Masako Mizuno-Kamiya (Awdur), Naoki Umemura (Awdur), Eiji Takayama (Awdur), Harumi Kawaki (Awdur), Kenji Mitsudo (Awdur), Yasunori Muramatsu (Awdur), Shinichiro Sumitomo (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Elsevier, 2019-11-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Inflammation substantially affects the risk of oral malignancy. Pro-inflammatory cytokine, interferon (IFN)-γ, confers anti-tumor activity using several different mechanisms. Conversely, higher expression of interleukin (IL)-17 is associated with worse prognosis. Monocyte chemotactic protein (MCP)-1...